Featured Research

from universities, journals, and other organizations

Immune response to tumour cells could aid cancer battle

Date:
June 15, 2011
Source:
University of Leicester
Summary:
New research in the UK has yielded a novel immunotherapeutic approach with potential for cancer treatment.

New research at the University of Leicester has yielded a novel immunotherapeutic approach with potential for cancer treatment.

Related Articles


Malignant tumours are the second main cause of death worldwide, with haematological malignancies representing 10%. Current treatment strategies, such as chemotherapy, radiotherapy, stem cell transplantation, or a combination of them, are mostly effective but may induce serious side effects to normal tissues. In addition, tumours are developing resistance against most of these conventional therapies.

A PhD student with the Department of Infection, Immunity and Inflammation, Yehia Mohamed, has shown that tumour "hybrid" cell lines can induce immune responses against tumour cells in the lab, as opposed to directly attacking them. As a result, the patients' tumour cells, as well as related cell lines, were killed, his findings reveal.

With tumour cells evolving mechanisms for evading the immune responses and making the development of strategies for inducing strong anti-tumour immunity difficult, Mohamed's research comes at a right time by providing a new solution for this issue.

Mohamed explained: "The tumour-specific cellular vaccines were created by fusing blood related tumour cells with the immunostimulatory cell line HMy2. These fusion cells showed enhanced ability to stimulate immune responses in blood cells from both tumour patients and normal individuals. His results suggest that hybrid cell lines could be used as immunotherapeutic agents for treatment of several types of haematological and non-haematological tumours.

"These data provide promising hope for developing more effective, safe, and long-lasting therapies of different types of tumours."

Dr Michael Browning, of the Department of Infection, Immunity and Inflammation, added: "There is growing evidence that the immune system plays a role in preventing cancer development, and that activating immune effectors in the right way may offer novel forms of cancer treatment.

"If developed further, the methods used in Mohamed's PhD project could offer a new way of treating certain cancer patients, by inducing tumour-killing cells from their blood in the lab, and then giving them back to the patient to seek out and kill any remaining tumour cells."


Story Source:

The above story is based on materials provided by University of Leicester. Note: Materials may be edited for content and length.


Cite This Page:

University of Leicester. "Immune response to tumour cells could aid cancer battle." ScienceDaily. ScienceDaily, 15 June 2011. <www.sciencedaily.com/releases/2011/06/110615062304.htm>.
University of Leicester. (2011, June 15). Immune response to tumour cells could aid cancer battle. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2011/06/110615062304.htm
University of Leicester. "Immune response to tumour cells could aid cancer battle." ScienceDaily. www.sciencedaily.com/releases/2011/06/110615062304.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins